A Phase III, Randomized, Open-label, Controlled, Multi-C

  • Gupta, Shilpa (PI)

Project: Research project

Project Details

Description

A Phase III, Randomized, Open-label, Controlled, Multi-Center, Global Study of First-Line MEDI4736 Monotherapy and MEDI4736 in Combination with Tremelimumab Versus Standard of Care Chemotherapy in Patients
StatusFinished
Effective start/end date11/15/154/1/19

Funding

  • AstraZeneca

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.